The Effect of Functional Dairy Products Enriched With Dietary Fibers on Human Health and Gut Microbiota
NCT ID: NCT04811157
Last Updated: 2021-03-23
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
90 participants
INTERVENTIONAL
2020-04-01
2020-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Hypothesis 1: Intake of dietary fibers improves the blood lipid profile of the participants.
Hypothesis 2: Intake of dietary fibers stabilizes the gut microbiome (e.g., low diversity) of the participants, improves gut health and normalizes gastrointestinal function and bowel habits.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Dietary Fiber and Gut Microbiome Study
NCT05424640
Effect of the Consumption of a Fermented Dairy Product Enriched With Plant Sterols
NCT01521156
Pilot Study in the Cholesterol Absorption Reduction After Consumption of Low-fat, Drinkable Fermented Milk Enriched With Plant Sterols
NCT01571869
Gut Health Response to Dietary Fiber
NCT01321736
Effect of the Consumption of a Fermented Milk Enriched With Plant Sterols (France)
NCT01574469
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
PRE-STUDY EVALUATION AND TESTING
1. Complete pre-study questionnaire
2. Complete orientation to the study and provide voluntary consent to join the study
3. Collection of coded intervention products, sampling supplies, and instructional materials 0-WEEK QUESTIONNAIRE AND LABORATORY VISIT
1\. Record food intake and gastrointestinal function for 3 days 2. Collect health data and provide a 3-day food frequency questionnaire 3. Provide a stool and blood sample at the laboratory 2-WEEK QUESTIONNAIRE AND LABORATORY VISIT
1. Record food intake and gastrointestinal symptoms for 3 days
2. Collect health data and provide a 3-day food frequency questionnaire
3. Provide a stool and blood sample at the laboratory BLOOD SAMPLE ANALYSES
1\. Provide the blood sample at the laboratory in the morning in an overnight fasted state.
DIETARY INTERVENTION
1\. Daily intake of a test or control product for two weeks.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
BASIC_SCIENCE
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Test group
Healthy adults consuming test product
Test product
200 g/day of unsweetened yogurt supplemented with a dietary fiber blend
Control group
Healthy adults consuming control product
Control product
200 g/day of unsweetened yogurt
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Test product
200 g/day of unsweetened yogurt supplemented with a dietary fiber blend
Control product
200 g/day of unsweetened yogurt
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Normal bowel function
* Regular consumer of dairy products, willing to consume dairy products daily for 2 weeks
* Ability to provide a signed written informed consent
* Willing to provide stool and blood specimens 2 times over the 2-week study period
Exclusion Criteria
* Medication: statins, blood pressure medications, antidepressants, other prescription medications
* History of bariatric operation, removal of the gallbladder.
* Food allergies, lactose intolerance
* Recent (previous 3 months) use of antibiotics
* Intake of highly dosed pre- or probiotics 2 weeks prior and during the study
* Current pregnancy or breastfeeding
* Volunteers showing previously unrecognized illness will also be excluded
* Individual unable to give informed consent
25 Years
55 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
SYNLAB Eesti OÜ, Tallinn, Estonia
UNKNOWN
AS FARMI Piimatööstus, Jõhvi, Estonia
UNKNOWN
Center of Food and Fermentation Technologies
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Madis Jaagura
Project Manager
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Madis Jaagura, MSc
Role: PRINCIPAL_INVESTIGATOR
TFTAK
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Center of Food and Fermentation Technologies
Tallinn, Harju, Estonia
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Informed Consent Form
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2014-2020.4.02.19-0198
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.